Luca Malorni

17PUBLICATIONS
115CO-AUTHORS
Predictive and prognostic markersCancer diagnosisMolecular targetsDeep learningCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jan 26, 2026
Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.

Giampaolo Bianchini, Luca Malorni, Roberta Caputo

|Dec 22, 2025
ctDNA Detection with Low-Pass Whole-Genome Bisulfite Sequencing in RAS Wild-Type Metastatic Colorectal Cancer: An Exploratory Objective of the VALENTINO Trial.

Paolo Manca, Marta Paoli, Francesca Galardi

|Mar 08, 2025
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer.

Riccardo Scandino, Agostina Nardone, Nicola Casiraghi

|Mar 01, 2024
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.

Ilenia Migliaccio, Dario Romagnoli, Francesca Galardi

|Feb 28, 2024
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer.

Marina Bacci, Nicla Lorito, Alfredo Smiriglia

|Feb 21, 2024
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer.

Cristina Guarducci, Agostina Nardone, Douglas Russo

Pageof 3

Frequent Collaborators

8 joint publications

Matteo Benelli

5 joint publications

Laura Biganzoli

4 joint publications

Chiara Biagioni

3 joint publications

Amelia McCartney